The nitric oxide donor pentaerythritol tetranitrate lowers hypertension and angiogenic imbalance in pregnancies with impaired uterine perfusion—a secondary analysis of a randomized trial - 02/02/26
On behalf of the
PETN study group
Video |
Plan
| Current affiliations: Department of Obstetrics, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany (Dr Groten); Department of Obstetrics and Gynecology, AND Institute of Midwifery, University Hospital of Würzburg, Würzburg, Germany (Dr Pecks); Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Dr Verlohren). |
|
| The authors report no conflict of interest. |
|
| Funding for this trial was provided by the German research foundation to T.G. (GR1955/4-1). The funding organization is a public institution and had no role in the design and conduct of the study; collection, management, and analysis of the data; or preparation, review, approval of the manuscript and decision to submit the manuscript for publication. |
|
| The trial was registered at Deutsches Register Klinischer Studien (DRKS) (DRKS00011374) on June 27, 2017, ( navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00011374 ) and ClinicaltTials.gov (NCT03669185) ( NCT03669185 ) on the September 14, 2018, with the clinical trial identification number EudraCT (2016-004396-51). The date of initial participation enrolment was the August 15, 2017. |
|
| The data set will be available to appropriate academic parties on request from the Chief Investigator, Tanja Groten, in accordance with the data sharing policies of the Jena University Hospital and the German research foundation. Input from the co-investigator group will be evaluated when applicable. The study protocol is available at PMC6744635 . |
Vol 234 - N° 2
P. e28-e36 - février 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?


